Navigation Links
Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
Date:5/20/2008

Results from Phase One of Two-Phase Examination of U.S. Asthma Control

RESEARCH TRIANGLE PARK, N.C. and TORONTO, May 20 /PRNewswire-FirstCall/ -- Nearly half of adult Americans with asthma and more than a quarter of children with asthma who responded to a nationally representative survey do not have their disease well controlled, according to the Asthma USA survey, which was presented today at the International Conference of the American Thoracic Society meeting in Toronto.

The survey found that not well controlled asthma had significant medical consequences. Adults with uncontrolled asthma were more likely to require treatment with oral corticosteroids, visit the emergency department or be admitted to the hospital than those whose asthma was well controlled. Children with uncontrolled asthma were also more likely to require urgent medical care. Past research has shown that uncontrolled asthma can put patients at risk for increased asthma symptoms, sudden asthma attacks, hospitalizations and even death.

"We have made quantum leaps in asthma treatment in the last decade, but the Asthma USA results demonstrate that enormous numbers of patients are living with asthma that is still not well controlled, putting them at significant health risk," said David Stempel, MD, director of clinical medicine for GlaxoSmithKline. "These findings remind us that improvements in care have not been uniform and underscore the critical need to improve education for both patients and healthcare providers in the management of asthma."

According to the National Institutes of Health Guidelines for the Diagnosis and Management of Asthma, signs of poor asthma control include waking at night with asthma symptoms, trips to the hospital and the need for quick-relief medication such as albuterol more than twice a week for asthma symptoms.

The survey examined responses from more than 81,500 households, with asthma control assessed with the Asthma Control Test
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
2. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
3. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
4. One Year On, ALLERCA Hypoallergenic Cats Bring Sneeze Free Companionship to Allergy and Asthma Sufferers
5. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
6. Drug Reduces Airway Mucus in Preclinical Asthma Model
7. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
10. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
11. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...K, N.Y., Nov. 5 BioSpeci...rmaceutical company developing first-in-class coll...ial results for the third quarter ended September ... September of this year, the FDA,s Arthritis Advis...f 12-0, the approval of XIAFLEX(TM) for the treatm...
(Date:11/5/2009)...RTH, Texas, Nov. 5 Wound...today that it has entered into a Letter of Intent ...al Health Technologies, Inc. (OTC Bulletin Board: ...0,000 in cash and debt, 4,000,000 shares of WNDM a...NDM on the Veriscrip technology being acquired fro...
(Date:11/5/2009)..., Calif., Nov. 5 WaferGe...eading developer of state-of-the-art genetic analy...s, Ph.D. has joined the company,s Scientific Advis...ng and commercializing novel molecular diagnostics...on the development of computational biology system...
(Date:11/5/2009)...MOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-FirstC...("BMP Sunstone" or the "Company") today announced,...09 financial results on,Monday, November 9, 2009, ...ll hold a conference call at 5:00 pm ET on Novembe...Listeners may access the call by,dialing 1-888-713...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...ioness Inc., an innovative provider of advanced ne...very from central nervous system disorders, announ...’s largest provider of inpatient rehabilitat...ity of the NESS H200 Hand Rehabilitation System an...bilitation hospitals nationwide. , ...
...RUG DEVELOPMENT, ROCKVILLE, Md., July 30 Stem ce...d that Dr. Thomas Hazel will be,rejoining the comp... be,working with Dr. Karl Johe, Neuralstem,s Chair...ny,s upcoming clinical trial for ALS,(Amytrophic L...mplete,development of Neuralstem,s small molecule ...
... Development Of Lead Drug Candidates, MARKHAM, ON...d the,closing of a CDN $45 million Series C financ...ubishi Tanabe Pharma Corporation ("MTPC"), and sup... Vengrowth Advanced Life,Sciences Fund Inc., Caiss...an Medical Discoveries Fund Inc., T(2)C(2)/Bio 200...
Other Biology Technology: Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 2 Bioness Announces NESS H200 and L300 Systems to Be Available at 88 HealthSouth Hospitals Nationwide 3Neuralstem Fills Key Product Development Position 2Cytochroma Closes $45 Million Series C Financing 2Cytochroma Closes $45 Million Series C Financing 3
(Date:11/8/2009)...ers at Purdue University have discovered a new app... cord injuries using nano-spheres that could be in..., The synthetic "copolymer micelles" are drug-del...roughly 100 times smaller than the diameter of a r...how to deliver drugs for cancer treatment and othe...
(Date:11/6/2009)...in harmony with their arboreal hosts. But new rese...heir trees of choice, the ants can get destructive... in the November issue of the American Naturalist...ve trees, and it reopens a centuries-old debate on...s and certain species of plants and trees have coz...
(Date:11/5/2009)...rded a training grant in the amount of $2,756,719 ...rative Graduation Education and Research Training ...be awarded to Kent State. The grant, which is fund...t of 2009, runs through 2014. , The grant funds ...ic resource sensing (EARS). The purpose of the pro...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5Alcohol advertising self regulation not working as ads target younger drinkers 48311 1Alcohol advertising self regulation not working as ads target younger drinkers 48311 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2
...the results are receiving rave reviews from apple ...nd research, a new apple cultivar has been introdu...ing program of the Illinois, New Jersey, and India...apple will be sold under the name ,WineCrisp,. Sch...urces and Environmental Sciences at the University...
...produce, which includes packaged lettuces, has gre...tbreaks associated with these products. To reduce ...s are used for decontamination once the food is ha...e fields is equally important. Researchers from th...f California, Davis and University of Arizona), le...
...tigators have uncovered a mechanism that helps exp...lar mood disorder, also protects the brain from da...n the May 1 issue of the Journal of Clinical Inve...how that lithium promotes DNA repair in healthy ce...gest that lithium treatment could offer a way to p...
Other Biology News:Apple enthusiasts welcome WineCrisp 2Protecting fresh-cut produce 2Lithium may help radiation target cancer, spare healthy tissue 2Lithium may help radiation target cancer, spare healthy tissue 3
...nity Life Sciences can provide custom microplate c...croplate processing equipment that dispenses and w...mmodate virtually any lot size of the following fo... 8 and 12 well strips, 96 well microplate, ...
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH
Mynox Mycoplasma Elimination Reagent from Sigma-Aldrich
Biology Products: